• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Virus Evol . Identification of H3N2 NA and PB1-F2 genetic variants and their association with disease symptoms during the 2014-15 influenza season

tetano

Editor, Senior Moderator
Virus Evol


. 2021 Jun 4;7(1):veab047.
doi: 10.1093/ve/veab047. eCollection 2021 Jan.
Identification of H3N2 NA and PB1-F2 genetic variants and their association with disease symptoms during the 2014-15 influenza season


Deena R Blumenkrantz[SUP] 1 [/SUP], Thomas Mehoke[SUP] 2 [/SUP], Kathryn Shaw-Saliba[SUP] 1 3 [/SUP], Harrison Powell[SUP] 1 [/SUP], Nicholas Wohlgemuth[SUP] 1 [/SUP], Hsuan Liu[SUP] 1 [/SUP], Elizabeth Macias[SUP] 4 [/SUP], Jared Evans[SUP] 2 [/SUP], Mitra Lewis[SUP] 5 [/SUP], Rebecca Medina[SUP] 5 [/SUP], Justin Hardick[SUP] 5 [/SUP], Lauren M Sauer[SUP] 5 [/SUP], Andrea Dugas[SUP] 5 [/SUP], Anna DuVal[SUP] 3 [/SUP], Andrew P Lane[SUP] 6 [/SUP], Charlotte Gaydos[SUP] 3 5 [/SUP], Richard Rothman[SUP] 3 5 [/SUP], Peter Thielen[SUP] 2 [/SUP], Andrew Pekosz[SUP] 1 [/SUP]



Affiliations
Free PMC article

Abstract

The 2014-15 influenza season saw the emergence of an H3N2 antigenic drift variant that formed the 3C.2a HA clade. Whole viral genomes were sequenced from nasopharyngeal swabs of ninety-four patients with confirmed influenza A virus infection and primary human nasal epithelial cell cultures used to efficiently isolate H3N2 viruses. The isolates were classified by HA clade and the presence of a new set of co-selected mutations in NA (a glycosylation site, NAg+) and PB1-F2 (H75P). The NA and PB1-F2 mutations were present in a subset of clade 3C.2a viruses (NAg+F2P), which dominated during the subsequent influenza seasons. In human nasal epithelial cell cultures, a virus with the novel NAg+F2P genotype replicated less well compared with a virus with the parental genotype. Retrospective analyses of clinical data showed that NAg+F2P genotype viruses were associated with increased cough and shortness of breath in infected patients.

Keywords: H3N2; NA; PB1-F2; antigenic drift; human; influenza; symptoms.
 
Back
Top Bottom